These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 19027366)

  • 21. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
    J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Usefulness of FRAX and future issues in women's health].
    Hashimoto K; Ishitani K; Ohta H
    Clin Calcium; 2009 Dec; 19(12):1742-8. PubMed ID: 19949265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevention of osteoporosis and its economic aspects].
    Blachier C
    Cah Sociol Demogr Med; 1999; 39(2-3):271-82. PubMed ID: 10615567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Management of postmenopausal osteoporosis].
    Ribot C; Trémollières F; Pouillès JM
    Rev Prat; 2005 Feb; 55(4):393-400. PubMed ID: 15828618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoporosis: alternatives to estrogen treatment.
    Fitzpatrick LA
    Minn Med; 2003 Jan; 86(1):36-41. PubMed ID: 12585558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [How to prevent early postmenopausal fracture risk? Proposition of a strategy].
    Trémollieres F; Pouilles JM; Ribot C
    Gynecol Obstet Fertil; 2009 Jan; 37(1):50-6. PubMed ID: 19110461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Absolute risk for fracture and WHO guideline. Pharmacological intervention to prevent osteoporotic fractures in the elderly].
    Hosoi T;
    Clin Calcium; 2007 Jul; 17(7):1098-104. PubMed ID: 17607078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of menopausal hormone therapy in osteoporosis.
    de Villiers T
    Climacteric; 2007 Oct; 10 Suppl 2():71-3. PubMed ID: 17882677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of postmenopausal osteoporosis].
    Chapurlat R; Delmas PD
    Rev Prat; 2004 Dec; 54(19):2120-6. PubMed ID: 15724589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Justification for the use of HRT in the long-term prevention of osteoporosis.
    Stevenson JC
    Maturitas; 2005 Jun; 51(2):113-26. PubMed ID: 15917151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention and treatment of postmenopausal osteoporosis.
    Lewiecki EM
    Obstet Gynecol Clin North Am; 2008 Jun; 35(2):301-15, ix. PubMed ID: 18486843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment strategies for patients with low bone mass: the younger postmenopausal female.
    Honig S
    Bull NYU Hosp Jt Dis; 2008; 66(3):240-3. PubMed ID: 18937639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintaining skeletal health among postmenopausal women.
    Ettinger B
    Am J Manag Care; 1998 Mar; 4(3):387-96. PubMed ID: 20919444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overview of bone mineral density in postmenopausal women.
    Notelovitz M
    J Reprod Med; 2002 Jan; 47(1 Suppl):71-81. PubMed ID: 11829080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis].
    Ohta H
    Clin Calcium; 2008 Oct; 18(10):1442-50. PubMed ID: 18830041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2005 May; 142(10):855-60. PubMed ID: 15897536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The HRT misuse and osteoporosis epidemic: a possible future scenario.
    Gambacciani M; Ciaponi M; Genazzani AR
    Climacteric; 2007 Aug; 10(4):273-5. PubMed ID: 17653953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009].
    Dimai HP; Pietschmann P; Resch H; Preisinger E; Fahrleitner-Pammer A; Dobnig H; Klaushofer K;
    Wien Med Wochenschr Suppl; 2009; (122):1-34. PubMed ID: 19484202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trend in incidence of osteoporosis-related fractures among 40- to 69-year-old women: analysis of a large insurance claims database, 2000-2005.
    Islam S; Liu Q; Chines A; Helzner E
    Menopause; 2009; 16(1):77-83. PubMed ID: 18703983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological options to enhance periprosthetic bone mass.
    Tsiridis E; Gamie Z; Conaghan PG; Giannoudis PV
    Injury; 2007 Jun; 38(6):704-13. PubMed ID: 17477926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.